H. Baghi, S. Noorbaloochi, and J. Moore. Quality management in health care, 16 (2):
104-12(2007)5152<m:linebreak></m:linebreak>JID: 9306156; RF: 65; ppublish;<m:linebreak></m:linebreak>Significació estadística.
Y. Chi, and C. Chen. Statistics in medicine, 27 (29):
6175-89(December 2008)5263<m:linebreak></m:linebreak>LR: 20090730; JID: 8215016; 0 (Antineoplastic Agents); 33419-42-0 (Etoposide); ppublish;<m:linebreak></m:linebreak>Fase II.
N. Freemantle, M. Calvert, J. Wood, J. Eastaugh, and C. Griffin. JAMA : the journal of the American Medical Association, 289 (19):
2554-9(May 2003)3350<m:linebreak></m:linebreak>Comparacions múltiples; Composite endpoints.
G. Norman, F. Sridhar, G. Guyatt, and S. Walter. Medical care, 39 (10):
1039-47(October 2001)4454<m:linebreak></m:linebreak>LR: 20041117; PUBM: Print; JID: 0230027; CIN: Med Care. 2001 Oct;39(10):1037-8. PMID: 11567166; ppublish;<m:linebreak></m:linebreak>MDCI.
L. Thabane, G. Wells, R. Cook, R. Platt, J. Pogue, E. Pullenayegum, D. Matthews, T. McCready, P. Devereaux, J. Cairns and 1 other author(s). Trials, (January 2011)6243<m:linebreak></m:linebreak>GR: Canadian Institutes of Health Research/Canada; JID: 101263253; OID: NLM: PMC3049182; 2010/11/14 received; 2011/02/18 accepted; 2011/02/18 aheadofprint; epublish;<m:linebreak></m:linebreak>Recursos/Organització; Consulting.
M. Brookhart, and S. Schneeweiss. The international journal of biostatistics, 3 (1):
Article 14(January 2007)5028<m:linebreak></m:linebreak>Variables instrumentals.
G. Cordoba, L. Schwartz, S. Woloshin, H. Bae, and P. Gøtzsche. BMJ (Clinical research ed.), (January 2010)5713<m:linebreak></m:linebreak>JID: 8900488; CIN: BMJ. 2010;341:c3529. PMID: 20719822; OID: NLM: PMC2923692; epublish;<m:linebreak></m:linebreak>Comparacions múltiples; Composite endpoints.
H. Kraemer, and E. Frank. JAMA : the journal of the American Medical Association, 304 (6):
683-4(August 2010)5721<m:linebreak></m:linebreak>JID: 7501160; ppublish;<m:linebreak></m:linebreak>Tamaño del efecto; Mesures de resultats; Relació benefici/risc; RCT.
J. Pildal, A. Hróbjartsson, K. Jørgensen, J. Hilden, D. Altman, and P. Gøtzsche. International journal of epidemiology, 36 (4):
847-57(August 2007)5316<m:linebreak></m:linebreak>LR: 20080616; JID: 7802871; EIN: Int J Epidemiol. 2008 Apr;37(2):422; 2007/05/21 aheadofprint; ppublish;<m:linebreak></m:linebreak>Metaanàlisi.
R. Tuma. Journal of the National Cancer Institute, 101 (21):
1439-41(November 2009)5434<m:linebreak></m:linebreak>JID: 7503089; 0 (Antineoplastic Agents); 2009/10/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
M. Koller, T. Stijnen, E. Steyerberg, and J. Lubsen. Journal of clinical epidemiology, 61 (4):
365-72(April 2008)4586<m:linebreak></m:linebreak>PUBM: Print-Electronic; JID: 8801383; 2006/05/23 received; 2007/05/08 revised; 2007/05/10 accepted; 2007/10/15 aheadofprint; ppublish;<m:linebreak></m:linebreak>Mesures d'associació.
Y. Wang, L. Meyerson, Y. Tang, and N. Qian. Journal of the neurological sciences, 285 (1-2):
206-11(October 2009)5489<m:linebreak></m:linebreak>JID: 0375403; 0 (Antibodies, Monoclonal); 0 (Immunologic Factors); 0 (natalizumab); 2009/03/05 received; 2009/07/15 revised; 2009/07/22 accepted; 2009/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Count data.
A. Stang, and O. Kuss. International journal of epidemiology, 39 (2):
634-5(April 2010)5694<m:linebreak></m:linebreak>JID: 7802871; CON: Int J Epidemiol. 2008 Dec;37(6):1430-5. PMID: 18710887; 2009/01/15 aheadofprint; ppublish;.
C. Gerlinger, and T. Schmelter. Pharmaceutical statistics, 10 (5):
410-3(2011)6376<m:linebreak></m:linebreak>MDCI; Tests d'equivalència; Mesures de resultats.